Bone marrow involvement in breast cancer detected by positron emission tomography

被引：6
|
作者：
Lewanski, CR [1 ]
Kaplan, GR [1 ]
Potter, J [1 ]
Ashford, RFU [1 ]
Wong, WL [1 ]
机构：
[1] Charing Cross Hosp, Dept Radiotherapy, London W6 8RF, England
来源：
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 1999年 / 92卷 / 04期
关键词：
D O I：
10.1177/014107689909200410
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：193 / 195
页数：3
相关论文
共 50 条
  • [21] Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient
    Franc, Benjamin L.
    Hawkins, Randall A.
    SEMINARS IN ROENTGENOLOGY, 2007, 42 (04) : 265 - 279
  • [22] Occult cancer detected by positron emission tomography/computed tomography image fusion
    Watanabe, SI
    Tanaka, D
    Nakamura, Y
    Kariatsumari, K
    Furumori, K
    Ohkubo, J
    Sakata, R
    Takagi, K
    ANTICANCER RESEARCH, 2005, 25 (1B) : 459 - 461
  • [23] Recurrent Gastric Cancer Metastasizing to the Bone Marrow Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography/Contrast-Enhanced Computed Tomography Scan
    Gosavi, Atul
    Puranik, Ameya
    Agrawal, Archi
    Purandare, Nilendu
    Shah, Sneha
    Rangarajan, Venkatesh
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (04): : 445 - 446
  • [24] Lymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
    Koc, Zehra Pinar
    Kara, Pelin Ozcan
    Akdeniz, Aydan
    Yaldiz, Mehmet
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2020, 29 (02) : 85 - 87
  • [25] Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography
    Saiki, Yusuke
    Tomita, Naoto
    Uchida, Akiko
    Uemura, Yu
    Suzuki, Yoshinori
    Hirakawa, Tsuneaki
    Kato, Masayuki
    Hoshikawa, Masahiro
    Kawano, Tsuyoshi
    Nakamura, Naoya
    Miura, Ikuo
    Arai, Ayako
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 675 - 681
  • [26] Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography
    Yusuke Saiki
    Naoto Tomita
    Akiko Uchida
    Yu Uemura
    Yoshinori Suzuki
    Tsuneaki Hirakawa
    Masayuki Kato
    Masahiro Hoshikawa
    Tsuyoshi Kawano
    Naoya Nakamura
    Ikuo Miura
    Ayako Arai
    International Journal of Hematology, 2021, 113 : 675 - 681
  • [27] Fluorine-18 Fluorodeoxyglucose with Positron Emission Tomography Revealed Bone Marrow Involvement in Sarcoidosis Patients with Anaemia
    de Prost, Nicolas
    Kerrou, Khaldoun
    Sibony, Mathilde
    Talbot, Jean-Noel
    Wislez, Marie
    Cadranel, Jacques
    RESPIRATION, 2010, 79 (01) : 25 - 31
  • [28] POSITRON EMISSION TOMOGRAPHY (PET) IN BREAST CANCER DIAGNOSIS
    Sayman, Haluk Burcak
    JOURNAL OF BREAST HEALTH, 2009, 5 (02): : 69 - 72
  • [29] Is there a role for positron emission tomography in breast cancer staging?
    Hodgson, Nicole C.
    Gulenchyn, Karen Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 712 - 720
  • [30] Role of positron emission tomography in the management of breast cancer
    Smith, IC
    Gilbert, FJ
    BREAST, 1999, 8 (06): : 303 - 310
12345